Skip to main content
Home

Breadcrumb

  1. Home
  2. News
  3. Search results
Displaying results 1351 - 1375 of 2423 Clear search
electronRx Limited
Healthcare and Life Science, Science and Engineering 02 Jul 2024

Pulmonary fibrosis: challenges in diagnosis, treatment and management

Pulmonary fibrosis (PF) is a progressive lung disease characterised by fibrosis or scarring of the lung tissue. As the disease progresses the build-up of fibrotic tissue causes the lungs to stiffen, limiting their ability to expand and contract, resulting in declines in lung function.

Career Ambitions
Healthcare and Life Science, Information Technology and Telecoms, Knowledge Intensive Services, Science and Engineering 01 Jul 2024

Are you going through a career slump?

If you were to score out of 10 how excited and motivated you feel about your work (and career) what number would you give it? If you score it 8, 9 or 10, give yourself a big pat on the back - you are really fortunate! If you give it a 6 -7 out of 10, there is room for improvement... Anything less than 6 needs serious action!

electronRx Limited
Communications, Healthcare and Life Science, Information Technology and Telecoms, Science and Engineering 27 Jun 2024

Transforming Healthcare Podcast: bridging industry and academia for innovation

In this episode host Dr.

Zyme Communications
Healthcare and Life Science 27 Jun 2024

Bio-Rad launches Celselect Slides 2.0 to advance rare cell and circulating tumor cell enrichment for cancer research

New Celselect Slides™ Design Increases Efficiency of Circulating Tumor Cell Capture from Liquid Biopsy Samples for Enumeration and Downstream Applications

Hercules Calif. — Bio-Rad Laboratories, Inc.

CN Bio Innovations Ltd
Healthcare and Life Science 27 Jun 2024

CN Bio appoints Lydia Seymour as VP People and Culture to further strengthen leadership team

Key appointment to support continued UK and US team expansion

Cambridge, UK, 27: CN Bio, a leading provider of single- and multi-organ microphysiological systems, announces the appointment of Lydia Seymour as Vice President of People and Cultur

Codon Communications
Healthcare and Life Science, Science and Engineering 26 Jun 2024

ELRIG UK and The Protein Society partner to advance protein sciences in drug discovery

Cambridge, UK and Los Angeles, US: The European Laboratory Research & Innovation Group (ELRIG) UK, a not-for-profit, volunteer-led organisation for the drug discovery community, has partnered with The Protein Society (TPS), an international, not-for-profit, scholarly society,

CRA International (UK) Limited
Healthcare and Life Science, Knowledge Intensive Services 25 Jun 2024

ASCO 2024 review: The benefits and barriers of biomarkers in oncology

Once again, Chicago saw the gathering of oncologists to discuss the latest developments in cancer. This year, considerable emphasis was placed on antibody-drug conjugates (ADCs), with several sessions dedicated exclusively to this technology.

Zyme Communications
Healthcare and Life Science 25 Jun 2024

Sapio Sciences introduces Sapio GMP LIMS offering unmatched flexibility for unique manufacturing processes

Sapio Sciences announces key new capabilities to its highly flexible, no/low-code LIMS to support laboratories that must comply with GMP, 21 CFR 11, and EU Annex 11 standards

Baltimore, MD: Sapio Sciences

Codon Communications
Cleantech and Environment, Healthcare and Life Science, Science and Engineering, Other 25 Jun 2024

Primerdesign launches real-time PCR workflow for onsite detection of Norovirus in Oysters

genesig Easy_oys Detection Kit offers rapid and reliable qPCR workflow to quantify Norovirus GI and GII pathogens in oyster tissue Onsite analysis helps ensure shellfish quality and safety across the production line, reducing public health risk De
Zyme Communications
Healthcare and Life Science 24 Jun 2024

Bio-Rad extends range of anti-biotherapeutic antibodies to accelerate antibody drug development

Four New Anti-Idiotypic Antibodies and a New Anti-MMAE Antibody Range Support Bioanalytical Assay Development for Preclinical Research and Clinical Trials

Hercules, Calif - Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products

VacZine Analytics Ltd (Assay Advantage)
Healthcare and Life Science, Science and Engineering 24 Jun 2024

mRNA influenza vaccines – VacZine Analytics forecast a third of global market value in 2030

This month VacZine Analytics, a specialist in infectious diseases and vaccines commercial analysis publishes a brand-new global analysis of the seasonal influenza vaccine market including mRNA products (monovalent and combinations)

Zyme Communications
Healthcare and Life Science 20 Jun 2024

Bio-Rad launches ddSEQ™ Single-Cell 3' RNA-Seq Kit for Single-Cell Gene Expression

ddSEQ™ Single-Cell 3' RNA-Seq Kit and Omnition v1.1 Analysis Software Enable High-Quality and Affordable Single-Cell Transcription and Gene Expression to Support Molecular Biology, Oncology, and Drug Discovery Research.

CRA International (UK) Limited
Uptake of advanced therapies in psoriasis and psoriatic arthritis
Healthcare and Life Science, Knowledge Intensive Services 19 Jun 2024

Uptake of advanced therapies in psoriasis and psoriatic arthritis

he uptake of innovative advanced treatments in immunology is highly dependent on the indication, with new innovative treatments gaining market share quickly in psoriasis, while older entrenched products still hold considerable market share in psoriatic arthritis.

electronRx Limited
Charity and Social Care, Healthcare and Life Science, Science and Engineering 19 Jun 2024

Exploring the complexities of Pulmonary Hypertension

Pulmonary hypertension (PH) is a serious condition characterised by elevated blood pressure within the pulmonary arteries. The pulmonary arteries are responsible for carrying blood from the right-hand side of the heart to the lungs.

Milner Therapeutics Institute, University of Cambridge
Education, Healthcare and Life Science, Science and Engineering 18 Jun 2024

Milner Therapeutics Institute Director Professor Tony Kouzarides awarded a knighthood in King's Birthday Honours List

Professor Tony Kouzarides, Director of the Milner Therapeutics Institute, has been awarded a knighthood for services to healthcare innovation and delivery.

Zyme Communications
Healthcare and Life Science 18 Jun 2024

Gyros Protein Technologies introduces Gyrolab Generic Anti-AAV Kit to support gene therapy development

Ready-to-use kit enables detection of binding antibodies against AAV vectors without the need for serotype-specific assays

WaveFX - video production & event streaming
Communications, Healthcare and Life Science, Information Technology and Telecoms, Knowledge Intensive Services 18 Jun 2024

Animating the science of a firearm - WaveFX

WaveFX writes...our talented CG artists can bring any process to life, for example this STEM based client wanted to show the firing process of a firearm as part of a series of educational videos.

Price Bailey Chartered Accountants
Healthcare and Life Science 17 Jun 2024

Price Bailey encourages Cambridge based healthcare businesses looking to sell, to act now

With the general election announced for July,  Price Bailey is urging healthcare businesses to sell up now to avoid potential post-election tax hikes. 

Zyme Communications
Healthcare and Life Science 17 Jun 2024

Enterprise Therapeutics appoints Dr Renu Gupta as Chief Medical Officer and Dr Janet Hammond as Non-Executive Director

Brighton, UK: Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of patients suffering from respiratory disease, announces the appointment of Dr Renu Gupta as CMO (Chief Medical

Sphere Bio
Healthcare and Life Science 17 Jun 2024

Sphere Fluidics awarded Gold accreditation by Investors in People

Internationally-recognized ‘We invest in people’ award is certified recognition of the Company’s care and commitment to its employees globally

Zyme Communications
Healthcare and Life Science 12 Jun 2024

Enterprise Therapeutics publishes preclinical profile of ETD001, a novel inhaled ENaC blocker

Low doses of ETD001 demonstrate exceptionally long duration of action in sheep model of airway mucus clearance Report in Journal of Cystic Fibrosis discloses best-in-class profile of ETD001 ETD001 scheduled to commence Phase 2 clinical study in p
Zyme Communications
Healthcare and Life Science 11 Jun 2024

Newcells Biotech strengthens executive and US team with key appointments

Dr Valeria Chichagova appointed as Director of Technology, Dr Colin Brown as Chief Scientific Officer, and Professor Lyle Armstrong as Scientific Advisor New US commercial appointments also announced to meet growing global demand for products and services
Cambridge Management Consulting Limited
Communications, Healthcare and Life Science, Information Technology and Telecoms, Manufacturing 11 Jun 2024

Cambridge-based Cofinitive Communications recognised amongst international PR and Communications industry elite

Cambridge-based PR & Comms agency, Cofinitive Communications has been listed in PR Week’s Top 150 PR agency rankings for a third consecutive year.

Creative Nutritionist
Education, Healthcare and Life Science 10 Jun 2024

I do not live with diabetes – should I be monitoring my glucose with CGM?

Nowadays, CGMs are being promoted by various biotech companies and social media influencers as tools for understanding and improving health. Unfortunately, I can see a rise in poorly evidenced health messages. In addition, there are many misleading ads risking people’s health.

Nuclera
Healthcare and Life Science 07 Jun 2024

Nuclera awarded £1.14M Innovate UK funding for development of eProtein Discovery

£790k FASST grant, in collaboration with DeepMirror, and £350k Engineering Biology grant awarded for platform development.

Pagination

  • First page «
  • Previous page ‹
  • …
  • Page 53
  • Page 54
  • Current page 55
  • Page 56
  • Page 57
  • …
  • Next page ›
  • Last page »
Receive our newsletter

Cambridge Network Limited is a company registered in England under company No. 3400152

The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

Email: [email protected], Tel: 01223 746801

© 2026 Cambridge Network. All Rights Reserved.

Website by KISS